• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Sanofi Aventis

edit

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2008, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases.

Milestones

edit

• 
  Sanofi Aventis invested in Rib-X Pharmaceuticals. (2/7/12)
  Posted 2/7/12 at 9:04pm via masshightech.com
• 
  Sanofi Aventis invested in Warp Drive Bio. (1/11/12)
  Posted 1/11/12 at 9:41pm via finsmes.com
• 
  Sanofi Aventis invested in Regulus Therapeutics. (10/28/10)
  Posted 10/28/10 at 6:07pm via finsmes.com
• 
  Sanofi Aventis invested in Metabolex. (6/25/10)
  Posted 6/25/10 at 7:10pm via fiercebiotech.com
• 
  Sanofi Aventis invested in Ascenta Therapeutics. (6/4/10)
  Posted 6/7/10 at 3:23am via fiercebiotech.com
• 
  Sanofi Aventis acquired Genzyme for $20B. (2/16/11)
  Posted 2/16/11 at 8:40pm via masshightech.com
• 
  Sanofi Aventis acquired TargeGen for $635M. (6/30/10)
  Posted 6/30/10 at 5:54pm via fiercebiotech.com
• 
  Sanofi Aventis acquired Merial Limited for $4B. (7/13/09)
  Posted 9/24/09 at 4:50pm via reuters.com
• 
  Sanofi Aventis acquired Shantha Biotechnics for $770M. (7/27/09)
  Posted 7/28/09 at 2:48pm via fiercebiotech.com
• 
  Sanofi Aventis acquired BiPar Sciences for $500M. (4/15/09)
  Posted 7/28/09 at 2:43pm via wsj.com
• 
  Sanofi Aventis — has simplified its name to Sanofi (5/9/11)
  Posted 5/10/11 at 2:52am via masshightech.com
• 
  Sanofi Aventis — Sanofi terminates $375M Metabolex diabetes deal (5/6/11)
  Posted 5/6/11 at 7:20pm via fiercebiotech.com
• 
  Sanofi Aventis — J&T will sale the shares of Zentiva (2/2/09)
  Posted 3/20/11 at 11:55pm via invest-iq.com
• 
  Sanofi Aventis — Sanofi-Aventis Poised to Purchase Additional Stake in Zentiva (1/1/09)
  Posted 3/20/11 at 11:54pm via invest-iq.com
• 
  Sanofi Aventis — Sanofi finally nails $20B+ deal to buy Genzyme (2/16/11)
  Posted 2/16/11 at 8:35pm via fiercebiotech.com
• 
  Sanofi Aventis — Genzyme Corp. officially announced the long-awaited approval of its sale to French pharmaceutical giant sanofi-aventis for approximately $20 billion in cash (2/16/11)
  Posted 2/16/11 at 8:46am via masshightech.com

Videos

Screenshots

edit

Sources

1. Sanofi paying $20B - and then some - for Genzyme (masshightech.com) [edit]
2. On a spree, Sanofi scoops up TargeGen in $635M dea Read more: On a spree, Sanofi scoops up TargeGen in $635M deal (fiercebiotech.com) [edit]
3. Sanofi snaps up India's Shantha for $784M (fiercebiotech.com) [edit]
4. Sanofi buys rest of Merial from Merck for $4 billion (reuters.com) [edit]
5. Sanofi to Buy BiPar Sciences (online.wsj.com) [edit]
6. Rib-X lands $3M milestone pay from Sanofi deal (masshightech.com) [edit]
7. Warp Drive Bio Raises $125M (finsmes.com) [edit]
8. Regulus Therapeutics Receives $10M Equity Investment from Sanofi-Aventis (finsmes.com) [edit]
9. Sanofi inks $375M deal with Metabolex for diabetes target Read more: Sanofi inks $375M deal with Metabolex for diabetes target - FierceBiotech http://www.fiercebiotech.com/story/sanofi-inks-375m-deal-metabolex-diabetes-target/2010-06-25?utm_medium=rss&ut (fiercebiotech.com) [edit]
10. Sanofi inks $398M cancer R&D deal with Ascenta Read more: Sanofi inks $398M cancer R&D deal with Ascenta (fiercebiotech.com) [edit]
11. Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement for novel oral agent to treat Type II Diabetes (en.sanofi-aventis.com) [edit]
12. Sanofi ejects two R&D sites, forges $2.2B pact with Covance (fiercebiotech.com) [edit]
13. Sanofi raises big loan as it plots Genzyme buyout strategy (fiercebiotech.com) [edit]
14. Report: Sanofi readies $20B deal package for Genzyme (fiercebiotech.com) [edit]
15. Sanofi, Genzyme agree on deal structure (fiercepharma.com) [edit]
16. Sanofi paying $20B - and then some - for Genzyme (masshightech.com) [edit]
17. Sanofi finally nails $20B+ deal to buy Genzyme (fiercebiotech.com) [edit]
18. Sanofi-Aventis Poised to Purchase Additional Stake in Zentiva (invest-iq.com) [edit]
19. J&T will sale the shares of Zentiva (invest-iq.com) [edit]
20. Sanofi terminates $375M Metabolex diabetes deal (fiercebiotech.com) [edit]
21. Sanofi drops aventis name (masshightech.com) [edit]